AMR Treatment Intelligence

Know

before

you treat.

CareU builds a digital twin of your patient’s immune system and simulates how infection and treatment will unfold—before the first dose is given.

Schedule a Demo →
scroll to see the platform
Antimicrobial Resistance Immune Digital Twin Within-Host Simulation ICU Decision Support AMR Treatment Intelligence Know Before You Treat Aarogya Sanskriti Phage Therapy Intelligence Antimicrobial Resistance Immune Digital Twin Within-Host Simulation ICU Decision Support AMR Treatment Intelligence Know Before You Treat Aarogya Sanskriti Phage Therapy Intelligence
Platform

Same patient.
Three protocols.
See the difference.

A 58-year-old patient. MDR Klebsiella bloodstream infection. Three evidence-based treatment options a physician would genuinely consider. CareU shows what happens to their immune system under each one.

ORGANISM
K. pneumoniae MDR
SITE
Bloodstream, ICU Day 1
NLR
14.2 — elevated
ALBUMIN
2.9 g/dL — low
eGFR
52 mL/min — impaired
AGE
58 years
// CareU — Immune Trajectory Simulation
LIVE
SELECT PROTOCOL TO SIMULATE
Meropenem — Extended infusion (4h)
2g q8h · optimised for eGFR 52
Class I
Meropenem — Standard bolus (30 min)
2g q8h · standard IV push
Class II
Colistin + Meropenem
combination · nephrotoxicity risk at eGFR 52
Class III
Immune activation index — 14-day trajectory for this patient
IMMUNE COLLAPSE ADEQUATE D3 D7 D14
MEROPENEM — EXTENDED INFUSION
Class I
Immune trajectory holds above the adequate threshold throughout 14 days. Extended infusion maximises time above MIC for this patient’s renal function. Clearance predicted day 5.
Resistance onsetHour 14.2
Immune at D70.82
Clearance81%
How It Works
01
Which organism is it?
Ranked probability from gram stain, ward context, and prior antibiotic exposure. Starts before culture confirms.
Gram stain
Ward / ICU
Prior antibiotics
02
Will this treatment succeed or fail?
Shows the hour resistance takes over. Before it happens. The physician decides — CareU shows the consequences.
Culture ID
Susceptibility panel
eGFR
03
Will their immune system finish the job?
A digital twin of this patient’s immune trajectory from NLR, albumin, and age. Two patients. Same diagnosis. Different biology. Different outcomes.
NLR
Albumin
Age
Steroid dose
1.27M
deaths per year // AMR

AMR is the silent pandemic. We are not waiting for it to get louder.

80% of AMR deaths occur where there is no computational decision support. Most happen in the 48-hour empiric window—before culture results return, before a physician knows what they are treating.

CareU is built for that window. It runs on a CBC and a gram stain. No specialist lab. No genomic sequencing.

Request Access

See CareU simulate a real patient.

30 minutes. A published MDR case, both phases, full immune trajectory. You see exactly what a physician in your setting would see.

Schedule a Demo →
// response within 48 hours